An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...

Brewer was terminated by Health and Human Services Sec. Robert F. Kennedy Jr. from the vaccine advisory panel in June.

House Judiciary Chair Jim Jordan subpoenaed Dr. Philip Dormitzer after he refused to testify in the 2020 vaccine delay probe, ...

It's a shot in the arm for Cambridge, Massachusetts-based Moderna as it faces an evolving regulatory environment for vaccines ...

U.S. Health and Human Services Sec. Robert F. Kennedy Jr. has gone against the scientific consensus on vaccines, and last month abruptly gutted the non-partisan, 17-member Advisory Committee on ...

Legislative changes in states like Maine and Colorado aim to protect vaccine access and adapt to federal policy shifts ...

The strategies that the industry’s lobbyists use, or don’t deploy, matter as the Trump administration moves more decisively against the industry than during his first term— pulling vaccine ...

A group of northeastern states, including Maine, New York, Rhode Island and Connecticut, are considering forming the group to ...

RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...

Moderna said on Monday its influenza vaccine was found to be 26.6% more effective than an approved annual flu shot from GSK ...

It's related to the omicron variant and is spreading in the U.S. now, causing more than 40% of Covid-19 cases.

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the ...